IV Iron Safety in Pregnancy

Evidence-Based Rationale

• The American College of Hematology recommends avoiding IV iron in the first trimester of pregnancy due to insufficient safety data, with oral iron being the recommended treatment for iron deficiency anemia during this period 1, 2
• The USPSTF noted that the use of intravenous iron was not assessed in their systematic review of iron supplementation in pregnancy, highlighting the evidence gap 3, 4

Recommended First Trimester Approach

• The Centers for Disease Control and Prevention recommends oral iron at 60-120 mg/day of elemental iron taken between meals for iron deficiency anemia 5
• The American College of Obstetricians and Gynecologists recommends starting low-dose oral iron supplementation at 30 mg/day at the first prenatal visit for primary prevention in all pregnant women 5

Clinical Indications for IV Iron

• The American Journal of Hematology suggests considering IV iron in the second or third trimester when oral iron fails after 4 weeks despite confirmed compliance and absence of acute illness 2
• The American Journal of Hematology also suggests considering IV iron when patients cannot tolerate oral iron preparations due to gastrointestinal side effects 2

Monitoring and Follow-Up

• The Centers for Disease Control and Prevention recommends reassessing hemoglobin after 4 weeks of oral iron treatment, expecting an increase of ≥1 g/dL or hematocrit increase of ≥3% 5, 2
• The Centers for Disease Control and Prevention also recommends referring to a physician familiar with anemia in pregnancy if hemoglobin is <9.0 g/dL or hematocrit is <27.0% 5, 2

Critical Safety Considerations

• The American Journal of Hematology states that fetal monitoring during or following IV iron administration is not required and not recommended 1
• The American Journal of Hematology also notes that the vast majority of infusion reactions are non-IgE-mediated and self-limited, not true anaphylaxis 1

Common Pitfalls to Avoid

• The American College of Obstetricians and Gynecologists recommends verifying patient compliance with oral iron, as gastrointestinal side effects frequently lead to discontinuation 2
• The USPSTF recommends not using hemoglobin or hematocrit alone to diagnose iron deficiency in pregnancy, as physiologic hemodilution can make these measurements imprecise 3, 4

Safety of IV Ferric Carboxymaltose in Pregnancy

Introduction to IV Ferric Carboxymaltose Safety

• The American College of Hematology recommends avoiding IV ferric carboxymaltose in the first trimester of pregnancy due to a lack of safety data, and instead suggests oral iron supplementation during this period 6

Evidence-Based Rationale for Avoiding First Trimester Use

• Administration of IV iron is generally avoided prior to the 13th week of gestation due to a lack of safety data, as stated by the American College of Hematology 6

When IV Iron Can Be Considered

• IV ferric carboxymaltose may be considered after 13 weeks gestation in patients with hemoglobin below 10 g/dL 7
• IV ferric carboxymaltose may be considered after 13 weeks gestation in patients with clinically active inflammatory bowel disease 7

Safety Profile in Second and Third Trimesters

• Fetal monitoring during or following IV iron administration is not required and is not recommended, according to the American College of Hematology 6

Critical Safety Considerations

• Parenteral iron administration may be associated with hypersensitivity reactions that can have serious consequences such as fetal bradycardia, and resuscitation facilities should be available when administering IV iron 8
• Ferric carboxymaltose is associated with treatment-emergent hypophosphatemia and should be avoided in patients requiring repeat infusions, with phosphate monitoring post-infusion recommended 6, 9

Common Pitfalls to Avoid

• Iron parameters should not be checked within 4 weeks of IV iron administration, as circulating iron interferes with assays leading to spurious results, according to the American College of Hematology 6, 9
• Ferritin may not accurately reflect iron stores in inflammatory states, as it is an acute phase reactant and may be falsely elevated, according to the American College of Hematology 6